ExodusPoint Capital Management, LP

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1736225 NEW YORK, NY

Position in RXRX

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$1,064,522

-$537,944 QoQ

Shares Held

346,750

-11.5% QoQ

Ownership

0.065%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

ExodusPoint Capital Management, LP holds $375,055,315 across 144 Biotechnology names. RXRX ranks #67 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	178,779	$33,798,169
2	INSM	INSMED Inc	148,133	$24,222,708
3	IONS	Ionis Pharmaceuticals Inc	227,084	$17,051,737
4	ABVX	Abivax S.A.	140,262	$15,618,173
5	COGT	Cogent Biosciences, Inc.	372,175	$14,325,015
6	VERA	Vera Therapeutics, Inc.	317,351	$12,767,030
7	BHVN	Biohaven Ltd.	1,501,099	$12,699,297
8	XENE	Xenon Pharmaceuticals Inc.	173,425	$10,084,663

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,064,522	346,750	-11.5%	Shares	Sole	2026-05-14
2025-12-31	$1,602,466	391,801	+90.9%	Shares	Sole	2026-02-17
2025-09-30	$1,001,556	205,237	+351.9%	Shares	Sole	2025-11-14
2025-06-30	$229,789	45,413	-26.4%	Shares	Sole	2025-08-13
2024-03-31	$615,039	61,689	+98.1%	Shares	Sole	2024-05-14
2023-03-31	$207,683	31,137	-32.1%	Shares	Other	2023-05-11
2022-09-30	$487,652	45,832	-76.1%	Shares	Sole	2022-11-10
2022-06-30	$1,563,474	192,073	+469.7%	Shares	Sole	2022-08-22
2022-03-31	$241,385	33,713	—	Shares	Sole	2022-05-13
No filing history on record for this holder in this stock.